How effective is Metronidazole for Clostridium Difficile Toxin Test Positive? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 0/5
This is a phase IV clinical study of how effective Metronidazole (metronidazole) is for Clostridium difficile toxin test positive and for what kind of people. The study is created by eHealthMe from 4 Metronidazole users and is updated continuously.
What is Metronidazole?
Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 59,578 Metronidazole users. Check the latest studies of Metronidazole.
What is Clostridium difficile toxin test positive?
Clostridium difficile toxin test positive is found to be associated with 8 drugs and 142 conditions by eHealthMe. Check the latest studies of Clostridium difficile toxin test positive.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4 people are studied for taking Metronidazole in Clostridium difficile toxin test positive
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Metronidazole effectiveness for Clostridium difficile toxin test positive (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 2
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 0
- very high: 0
Gender of people who take Metronidazole for Clostridium difficile toxin test positive *:
- female: 100 %
- male: 0.0 %
Age of people who take Metronidazole for Clostridium difficile toxin test positive *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 25 %
- 20-29: 25 %
- 30-39: 25 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 0.0 %
Who find Metronidazole more effective for Clostridium Difficile Toxin Test Positive?
Gender of people who take Metronidazole for Clostridium difficile toxin test positive *:
- female: 100 %
- male: 0.0 %
Age of people who take Metronidazole for Clostridium difficile toxin test positive *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 100 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Metronidazole?
- You can start a phase IV clinical trial to monitor Metronidazole safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Metronidazole (59,578 reports)
Treatments, associated drugs and conditions:
- Clostridium difficile toxin test positive (219 reports)
How the study uses the data?
The study is based on metronidazole (the active ingredients of Metronidazole) and Metronidazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metrogel cause Pelvic Pain? - 3 seconds ago
- Could Ranitidine cause Impaired Gastric Emptying? - 3 seconds ago
- Lupus Nephritis and Abdominal Pain - 9 seconds ago
- Lower Respiratory Tract Infection and Thrombocytopenia - 10 seconds ago
- Macular Degeneration and Hyphaema - 10 seconds ago
- Could Glucotrol cause Ankylosing Spondylitis? - 11 seconds ago
- Drug interactions of Levetiracetam and Mobic - 12 seconds ago
- Could Ramipril cause Paroxysmal Supraventricular Tachycardia? - 12 seconds ago
- Could Ranitidine Hydrochloride cause Cachexia? - 15 seconds ago
- Could Ramipril cause Injection Site Haemorrhage? - 20 seconds ago